Literature DB >> 27127440

Rapid Extracorporeal Membrane Oxygenation Overcomes Fulminant Myocarditis Induced by 5‑Fluorouracil.

Alok R Amraotkar, Ajay Pachika, Kendra J Grubb, Andrew P DeFilippis.   

Abstract

Fulminant myocarditis is a rare but potentially life-threatening illness caused by 5-fluorouracil cardiotoxicity. Data supporting the use of extracorporeal membrane oxygenation for the treatment of fulminant myocarditis are limited. A 49-year-old, previously healthy white man, recently diagnosed with anal squamous cell carcinoma, developed severe chest pain hours after completing his first 96-hour intravenous 5-fluorouracil treatment. Over a period of 3 days from onset of symptoms, the patient developed cardiogenic shock secondary to fulminant myocarditis induced by 5-fluorouracil cardiotoxicity. This required emergency initiation of extracorporeal membrane oxygenation. The patient's systolic function recovered by day 5, and on the 17th day he was discharged in hemodynamically stable condition, without symptoms of heart failure. This case shows the importance of prompt recognition of cardiogenic shock secondary to 5-fluorouracil-induced myocarditis and how the immediate initiation of extracorporeal membrane oxygenation can restore adequate tissue perfusion, leading to myocardial recovery and ultimately the survival of the patient.

Entities:  

Keywords:  Antineoplastic agents/cardiotoxicity; ECMO; colorectal neoplasms/drug therapy; fluorouracil/adverse effects/therapeutic use/toxicity; male; middle aged; myocarditis/chemically induced; treatment outcome

Mesh:

Substances:

Year:  2016        PMID: 27127440      PMCID: PMC4845572          DOI: 10.14503/THIJ-15-5100

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  23 in total

1.  Symptomatic cardiotoxicity associated with 5-fluorouracil.

Authors:  C C Meyer; K A Calis; L B Burke; C A Walawander; T H Grasela
Journal:  Pharmacotherapy       Date:  1997 Jul-Aug       Impact factor: 4.705

Review 2.  Fulminant myocarditis.

Authors:  Sachin Gupta; David W Markham; Mark H Drazner; Pradeep Pa Mammen
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-09-16

3.  Acutely severe myocarditis successfully treated by percutaneous cardiopulmonary support applied by a newly developed heparin-binding oxygenator and circuits.

Authors:  T Yasu; S Murata; T Katsuki; M Fujii; N Kubo; N Ohmura; T Ino; M Saito
Journal:  Jpn Circ J       Date:  1997-12

4.  Initial dose effect of 5-fluorouracil: rapidly improving severe, acute toxic myopericarditis.

Authors:  Ali Nazmi Çalık; Emel Çeliker; Yalçın Velibey; Metin Çağdaş; Özge Güzelburç
Journal:  Am J Emerg Med       Date:  2011-01-03       Impact factor: 2.469

5.  Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience.

Authors:  Kang-Hong Hsu; Nai-Hsin Chi; Hsi-Yu Yu; Chih-Hsien Wang; Shu-Chien Huang; Shoei-Shen Wang; Wen-Je Ko; Yih-Sharng Chen
Journal:  Eur J Cardiothorac Surg       Date:  2011-02-21       Impact factor: 4.191

6.  Cardiac lesions induced by 5-fluorouracil in the rabbit.

Authors:  P Tsibiribi; C Bui-Xuan; B Bui-Xuan; C Lombard-Bohas; S Duperret; M Belkhiria; A Tabib; G Maujean; J Descotes; Q Timour
Journal:  Hum Exp Toxicol       Date:  2006-06       Impact factor: 2.903

Review 7.  The spectrum of 5-fluorouracil cardiotoxicity.

Authors:  Jonathan R Dalzell; Leslie M Samuel
Journal:  Anticancer Drugs       Date:  2009-01       Impact factor: 2.248

8.  The appearance of endothelium in small arteries after treatment with 5-fluorouracil. An electron microscopic study of late effects in rabbits.

Authors:  M Cwikiel; J Eskilsson; J B Wieslander; U Stjernquist; M Albertsson
Journal:  Scanning Microsc       Date:  1996

9.  5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation.

Authors:  Z Sasson; C D Morgan; B Wang; G Thomas; B MacKenzie; M E Platts
Journal:  Can J Cardiol       Date:  1994-10       Impact factor: 5.223

10.  Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.

Authors:  Christos Kosmas; Manolis S Kallistratos; Petros Kopterides; John Syrios; Helias Skopelitis; Nicolaos Mylonakis; Athanasios Karabelis; Nicolas Tsavaris
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-17       Impact factor: 4.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.